Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$2.15 -0.10 (-4.44%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xtl Biopharmaceuticals (XTLB) Other Non-Interest Income (2020 - 2022)

Updated

Xtl Biopharmaceuticals (XTLB) recorded Other Non-Interest Income of -$230,000 in the quarter ended Mar 31, 2022, compared with -$1.04 million a year earlier.

Analysis

Xtl Biopharmaceuticals (XTLB) Other Non-Interest Income (2020 - 2022) Analysis & Trends

On a TTM basis, Xtl Biopharmaceuticals' Other Non-Interest Income came in at -$1.71 million as of Mar 31, 2022; for the year ended Dec 31, 2020, it was $166,000.

  • The figure for the quarter ended Mar 31, 2022 is the highest quarterly Other Non-Interest Income since the quarter ended Dec 31, 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Xtl Biopharmaceuticals 2.03 Bn 2.03 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -230,000.00
Mar 31, 2021 -1.04 Mn
Dec 31, 2020 -162,000.00
Mar 31, 2020 -270,000.00
API Access

Xtl Biopharmaceuticals Other Non-Interest Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-interest-income&ticker=XTLB&period=max&api_key=YOUR_API_KEY